Experts note that women over 35 who use oral contraceptives may face a higher risk of breast cancer, a point raised by a respected oncologist specializing in breast diseases at a major clinic. The message underscores a cautious approach to birth control for this age group.
In general, the likelihood of developing breast cancer tends to rise with age, peaking in the 50s and 60s. Hormone replacement therapy after menopause can help prevent osteoporosis but has been associated with an increased breast cancer risk. For women past 35, some clinicians suggest reevaluating the routine use of hormonal birth control, while recognizing that there are conditions where such contraception remains medically justified, including endometriosis, polycystic ovary syndrome, and other hormonal disorders that benefit from these medications.
Clinicians also point out that stopping hormonal contraception should be weighed against potential risks, such as a heightened chance of ovarian cancer, requiring careful consideration of individual risk factors and benefits for each patient in this age range.
Earlier research from a prominent university compared groups of women with and without breast cancer. It showed that a sizable portion of women in both groups had used hormonal birth control, with a higher proportion among those diagnosed with breast cancer. Overall, hormonal contraceptives were linked to an approximate 20–30% increase in breast cancer risk.
Experts emphasize that even though the numbers are meaningful, they reflect long-term exposure and the lifetime risk trajectory. The study design distinguishes it from earlier investigations by following participants over an extended period, offering a broader view of how risk accumulates.
Beyond medication choices, the emphasis remains on a healthy lifestyle as a key factor in lowering cancer risk. While modern medical systems excel in treatment, prevention still relies heavily on everyday habits. Regular screening and early detection play crucial roles in improving outcomes, though they do not guarantee a reduction in incidence.